First Disclosure of AZD9829, a TOP1i-ADC Targeting CD123: Promising Preclinical Activity in AML Models with Minimal Effect on Healthy Progenitors
Author:
Dipannita Dutta,Pan Pan,Ryan Fleming,Marcio Andrade-Campos,Elena Belova,Jennifer Wheeler,Patricia Cheung,Paul Santacroce,Casey Daniels,Darrin Sabol,Brad Jakubison,Benedicte Recolin,Andrew Dippel,Margaret Wey,Arthur Shaffer,Edward Rosfjord et al.
Copyright © 2023 The American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.